Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06976502

Health eHeart BioBank

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
500,000 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the Health eHeart BioBank is to collect and store specimen (e.g. blood, DNA, tissue) for future studies at the University of California, San Francisco (UCSF) that will help determine changes and identify molecular and genetic markers in the human body that might help increase our knowledge of heart disease and guide development of new diagnostic tools and treatments that may help rapidly detect heart disease and prevent and/or treat heart disease.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood DrawParticipants will be asked to contribute approximately 36 mL of blood using standard procedures and obtained at the time of a clinically ordered routine blood draw or a study ordered blood draw. Participants may be asked to contribute additional blood samples over the course of their participation in the study.
PROCEDURETissue CollectionIf the participant is undergoing a clinically ordered procedure (e.g. heart surgery/biopsy/transplant), then they will be asked to contribute tissue to the study before any tissue is collected during the procedure. Most samples collected by the HeH BioBank will be tissue that would be normally discarded after the procedure.
PROCEDUREDNA CollectionParticipants will be asked to contribute their DNA for Whole Genome Sequencing (WGS) to help identify genetic markers of heart disease. DNA will be obtained at the time of the blood draw or obtained through DNA collection kits administered to participants who are unable or unwilling to undergo a blood draw.
OTHERMedical Chart ReviewDemographic, clinical, and pathologic information will be extracted from the participant's medical record.

Timeline

Start date
2025-04-01
Primary completion
2035-12-01
Completion
2035-12-01
First posted
2025-05-16
Last updated
2025-06-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06976502. Inclusion in this directory is not an endorsement.